Trial Outcomes & Findings for Tracking Depression Symptoms With a Health Chatbot (NCT NCT03990389)

NCT ID: NCT03990389

Last Updated: 2022-05-12

Results Overview

Measured by the Edinburgh Postnatal Depression Scale (EPDS) Range 0-30 (dimensionless) Risk of depression goes up with an increasing score

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

3 months

Results posted on

2022-05-12

Participant Flow

Excluded Patient Subjects (n = 35) * EPDS \< 12 (n = 12) * Spanish speaking only (n = 2) * No Facebook account (n=1) * Consent not returned (n=18) * Refused (n = 2) No data was collected for the providers as no results related to the providers were reported.

Participant milestones

Participant milestones
Measure
No Intervention: Usual Care Group
Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.
Experimental: Chabot Care Group
Subjects will undergo screening including REALM-R and EPDS and a few additional questions.
Overall Study
STARTED
15
16
Overall Study
COMPLETED
12
16
Overall Study
NOT COMPLETED
3
0

Reasons for withdrawal

Reasons for withdrawal
Measure
No Intervention: Usual Care Group
Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.
Experimental: Chabot Care Group
Subjects will undergo screening including REALM-R and EPDS and a few additional questions.
Overall Study
Lost to Follow-up
3
0

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
No Intervention: Usual Care Group
n=15 Participants
Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.
Experimental: Chabot Care Group
n=16 Participants
Subjects will undergo screening including REALM-R and EPDS and a few additional questions.
Total
n=31 Participants
Total of all reporting groups
Age, Continuous
31.3 years
STANDARD_DEVIATION 4.4 • n=15 Participants
33.1 years
STANDARD_DEVIATION 2.7 • n=16 Participants
32.2 years
STANDARD_DEVIATION 3.7 • n=31 Participants
Sex: Female, Male
Female
15 Participants
n=15 Participants
16 Participants
n=16 Participants
31 Participants
n=31 Participants
Sex: Female, Male
Male
0 Participants
n=15 Participants
0 Participants
n=16 Participants
0 Participants
n=31 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: 3 months

Population: missing values at month 1, month 2, and month 3

Measured by the Edinburgh Postnatal Depression Scale (EPDS) Range 0-30 (dimensionless) Risk of depression goes up with an increasing score

Outcome measures

Outcome measures
Measure
No Intervention: Usual Care Group
n=15 Participants
Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.
Experimental: Chabot Care Group
n=16 Participants
Subjects will undergo screening including REALM-R and EPDS and a few additional questions.
Longitudinal Change in Depression Severity
baseline
16.13 score on a scale
Standard Error 1.17
14.06 score on a scale
Standard Error 1.13
Longitudinal Change in Depression Severity
month 1
10.47 score on a scale
Standard Error 1.29
10.69 score on a scale
Standard Error 1.13
Longitudinal Change in Depression Severity
month 2
8.23 score on a scale
Standard Error 1.33
11.35 score on a scale
Standard Error 1.19
Longitudinal Change in Depression Severity
month 3
9.64 score on a scale
Standard Error 1.33
10.87 score on a scale
Standard Error 1.16

SECONDARY outcome

Timeframe: 3 months

Population: Four missing values in the Usual Care Group and one missing value in the Chabot Care Group

Measured by the Computerized Adaptive Test-Depression Inventory (CAT-DI) and calculated change in Edinburgh Postnatal Depression Scale (EPDS) between Baseline and 3 months. Edinburgh Postnatal Depression Scale (EPDS) Range 0-30 (dimensionless) Risk of depression goes up with an increasing score

Outcome measures

Outcome measures
Measure
No Intervention: Usual Care Group
n=11 Participants
Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.
Experimental: Chabot Care Group
n=15 Participants
Subjects will undergo screening including REALM-R and EPDS and a few additional questions.
Change in Depression Severity
-6.2 score on a scale
Standard Deviation 4.3
-3.1 score on a scale
Standard Deviation 5.4

SECONDARY outcome

Timeframe: 3 months

Population: No data collected

Measured by the Frequency, Intensity, and Burden of Side Effects Rating (FIBSER) questionnaire

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months

Population: No data collected

Measured by the Barkin Index of Maternal Functioning

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months

Population: No data collected

Measured by Maternal Confidence Questionnaire

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months

Population: No data collected

Measured by 1-item medication adherence questionnaire

Outcome measures

Outcome data not reported

Adverse Events

No Intervention: Usual Care Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental: Chabot Care Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. David Beiser

The University of Chicago

Phone: 773-702-0307

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place